Literature DB >> 5123240

Anxiety, depression and psychotropic drugs.

L E Hollister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5123240     DOI: 10.2165/00003495-197101030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  7 in total

1.  CONTROLLED COMPARISON OF AMITRIPTYLINE, IMIPRAMINE AND PLACEBO IN HOSPITALIZED DEPRESSED PATIENTS.

Authors:  L E HOLLISTER; J E OVERALL; M JOHNSON; V PENNINGTON; G KATZ; J SHELTON
Journal:  J Nerv Ment Dis       Date:  1964-10       Impact factor: 2.254

2.  Drug therapy in depressions. Controlled evaluation of imipramine, isocarboxazide, dextroamphetamineamobarbital, and placebo.

Authors:  J E OVERALL; L E HOLLISTER; A D POKORNY; J F CASEY; G KATZ
Journal:  Clin Pharmacol Ther       Date:  1962 Jan-Feb       Impact factor: 6.875

Review 3.  Clinical use of psychotherapeutic drugs: current status.

Authors:  L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1969 Mar-Apr       Impact factor: 6.875

4.  Doxepin versus diazepam: a controlled evaluation in 100 chronic alcoholic patients.

Authors:  D M Gallant; M P Bishop; R Guerrero-Figueroa; M Selby; R Phillips
Journal:  J Clin Pharmacol J New Drugs       Date:  1969 Jan-Feb

5.  Severe emotional disturbance associated with physical illness. I. Double-blind study.

Authors:  J Coleman
Journal:  Psychosomatics       Date:  1969 May-Jun       Impact factor: 2.386

6.  Psychiatric drug research. Sample size requirements for one vs two raters.

Authors:  J E Overall; L E Hollister; S N Dalal
Journal:  Arch Gen Psychiatry       Date:  1967-02

Review 7.  Biogenic amines and emotion.

Authors:  J J Schildkraut; S S Kety
Journal:  Science       Date:  1967-04-07       Impact factor: 47.728

  7 in total
  3 in total

1.  A central nervous system depressant-antidepressant.

Authors:  A P Roszkowski; M E Schuler; M Mark; J A Edwards
Journal:  Experientia       Date:  1975-08-15

2.  Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  V Claassen; J E Davies; G Hertting; P Placheta
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

3.  Some considerations on the role of benzodiazepines in the treatment of depression.

Authors:  G B Cassano; L Conti
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.